Literature DB >> 7837243

Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in vitro potency.

P D Edwards1, D J Wolanin, D W Andisik, M W Davis.   

Abstract

A series of peptidyl alpha-ketoheterocycles were synthesized and evaluated for their in vitro inhibition of human neutrophil elastase (HNE). Several heterocycles, including oxazoline and benzoxazole, afforded extremely potent inhibitors of HNE (1p-r) with nanomolar to subnanomolar Ki values. The structure-activity relationships revealed that for compounds with a Ki < 1000 nM potency tends to be positively correlated with the sigma I value of the heterocycle. Furthermore, the results in this study support the hypothesis that, in the covalent enzyme-inhibitor adduct, the azole nitrogen atom of the inhibitor heterocycle participates in a hydrogen-bonding interaction with the active-site His-57.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7837243     DOI: 10.1021/jm00001a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  EMBM - a new enzyme mechanism-based method for rational design of chemical sites of covalent inhibitors.

Authors:  Tamar Traube; Subramaniam Vijayakumar; Michal Hirsch; Neta Uritsky; Michael Shokhen; Amnon Albeck
Journal:  J Chem Inf Model       Date:  2010-11-19       Impact factor: 4.956

2.  Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.

Authors:  F Anthony Romero; Wu Du; Inkyu Hwang; Thomas J Rayl; F Scott Kimball; Donmienne Leung; Heather S Hoover; Richard L Apodaca; J Guy Breitenbucher; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-02-06       Impact factor: 7.446

3.  Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

Authors:  D L Boger; H Sato; A E Lerner; M P Hedrick; R A Fecik; H Miyauchi; G D Wilkie; B J Austin; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Delineation of a fundamental alpha-ketoheterocycle substituent effect for use in the design of enzyme inhibitors.

Authors:  F Anthony Romero; Inkyu Hwang; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-11-01       Impact factor: 15.419

5.  Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles.

Authors:  Sivakoteswara Rao Mandadapu; Pathum M Weerawarna; Mallikarjuna Reddy Gunnam; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-05-26       Impact factor: 2.823

6.  Comprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α Inhibitors.

Authors:  Freek J Janssen; Marc P Baggelaar; Jessica J A Hummel; Herman S Overkleeft; Benjamin F Cravatt; Dale L Boger; Mario van der Stelt
Journal:  J Med Chem       Date:  2015-12-02       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.